Who we are | Profile

Verum has been the first Western-standard CRO with consulting and operational activities in Central and Eastern Europe since it was founded in 1996. As the first registered CRO in a number of Central/ and Eastern European countries, Verum staff has developed reliable business relationships with clinical sites, laboratories and scientific communities.

Having its headquarters office in Munich Biotech Cluster and traditionally providing services in the Region of Germany and Austria, Verum is also focusing on operational activities in Central and Eastern European countries with an overall population of 225 million people.

During more than 20 years the Company organized and handled numerous consulting and management services for medicinal product development for leading EU and US based pharmaceutical, biotechnology and medical device companies. Our aim is to support our clients throughout product/drug development projects and achieve Product Marketing Authorization in a cost-efficient and timely manner with the appropriate quality of data delivery.

The distinctive feature of the company is the established team of professionals with excellent academic training and substantial years-long experience in CT management in Western, Central and Eastern European countries.

Leading by senior management with long term CT experience in pharmaceutical companies, academic research organizations and CROs, Verum supports and manages operational aspects of clinical trials projects in varied therapeutic areas: cardiology, oncology, hematology, neuroscience, psychiatry, respiratory and infectious diseases , endocrinology, dermatology, and reproductive care medicine.

During the last two decades, more than 160 trials have been completed using our services. The high degree of customer satisfaction among the sponsors is shown in the 15 winning awards for quality, performance, and good business practice. Verum has been selected by the US National Institutes of Health (NIH) and National Institute of Neurological Disorders and Stroke (NINDS) to run a government-funded trial in Europe.

Verum’s core business and key competence is consulting and project-related services for both commercial and non-commercial clinical trials in Central and Eastern Europe. We are mostly specialized in neuroscience, oncology and hematology, respiratory, infectious and cardiovascular diseases. In the course of the last years, Verum is also focused on biosamples collection studies, conducted by developers and manufacturers of integrated systems for the analysis of genetic variation and biological function. We are experts in regulatory and ethic affairs for biosample collection studies in Europe.

Besides providing consulting and management in clinical trials, Verum created a partnership network with data management, biostatistics, IMP packaging and logistics companies with the purpose to provide one-contract, strong and competent service for our clients.